Sheng Ding

Corporate Officer/Principal presso

The University of California, San Francisco

Consumer Services

Health Technology

Profilo

Sheng Ding is the founder of Tenaya Therapeutics, Inc. (founded in 2016).
He is currently a Professor at The University of California, San Francisco.
Previously, he worked as an Assistant Professor at The Scripps Research Institute.
Dr. Ding holds a doctorate degree from The Scripps Research Institute and an undergraduate degree from California Institute of Technology.

Posizioni attive di Sheng Ding

Società	Posizione	Inizio
The University of California, San Francisco The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

Tutte le posizioni attive di Sheng Ding

Precedenti posizioni note di Sheng Ding

Società	Posizione	Fine
The Scripps Research Institute The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
TENAYA THERAPEUTICS, INC.	Fondatore	-

Vedi nel dettaglio l'esperienza di Sheng Ding

Formazione di Sheng Ding

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Sheng Ding

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
The Scripps Research Institute The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
California Institute of Technology California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of California, San Francisco The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tenaya Therapeutics, Inc. Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure	Health Technology